Literature DB >> 26866845

Autophagy is involved in the pathogenesis of experimental autoimmune neuritis in rats.

Shouhong Zhou1, Xiong Chen, Ruirui Xue, Qiaofeng Zhou, Pengju Hu, Xinping Ouyang, Tingting Dai, Wenting Zhu, Shaowen Tian.   

Abstract

Recent studies have shown that autophagy is involved in peripheral nervous system disease. However, the role of autophagy in the pathogenesis of experimental autoimmune neuritis (EAN) remains unclear. Therefore, EAN was induced by a subcutaneous injection into both hind footpads of synthetic neuritogenic P2(57-81) peptide in male Lewis rats. The clinical evaluation was completed using a 10-point scale method. The histological alteration of sciatic nerves was analyzed by hematoxylin and eosin and luxol fast blue staining. The ultrastructure of sciatic nerves was analyzed by transmission electron microscopy. Expressions of beclin-1 and microtubule-associated protein light chain-3 (LC3) and p62/SQSTM1 were determined by western blot. 3-Methyladenine, the inhibitor of autophagy, was used in this research. Results showed that the clinical scores were significantly increased from day 6 to day 16 after immunization compared with the control group. Compared with the control group, the number of inflammatory cells and the histological score of sciatic nerves were significantly increased, expressions of beclin-1 and LC3-II and the ratio of LC3-II/LC3-I in the sciatic nerve were significantly increased, and the expression of p62 was significantly decreased in the EAN model group. Considerable double-membrane autophagosomes in axons and myelin sheaths of sciatic nerves were observed and the number of autophagosomes in axons and myelin sheaths of sciatic nerves in the EAN model group was obviously increased compared with the control group. 3-Methyladenine ameliorated the neurologic severity of EAN. Our results suggest that autophagy activity in nerve tissue of EAN rats is increased, which may be associated with the pathogenesis of EAN.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26866845     DOI: 10.1097/WNR.0000000000000543

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  5 in total

Review 1.  Advances in the role of autophagy in the development of retinoblastoma.

Authors:  Teng Wan; Mingyuan Fu; Zhuan Wu; Xue Gao; Shouhong Zhou
Journal:  Oncol Lett       Date:  2021-07-01       Impact factor: 2.967

2.  Systemic application of 3-methyladenine markedly inhibited atherosclerotic lesion in ApoE-/- mice by modulating autophagy, foam cell formation and immune-negative molecules.

Authors:  Shen Dai; Bo Wang; Wen Li; Liyang Wang; Xingguo Song; Chun Guo; Yulan Li; Fengming Liu; Faliang Zhu; Qun Wang; Xiaoyan Wang; Yongyu Shi; Jianing Wang; Wei Zhao; Lining Zhang
Journal:  Cell Death Dis       Date:  2016-12-01       Impact factor: 8.469

Review 3.  Assessing Autophagy in Sciatic Nerves of a Rat Model that Develops Inflammatory Autoimmune Peripheral Neuropathies.

Authors:  Susana Brun; Nicolas Schall; Hélène Jeltsch-David; Jérôme de Sèze; Sylviane Muller
Journal:  Cells       Date:  2017-09-18       Impact factor: 6.600

4.  Progranulin deficiency confers resistance to autoimmune encephalomyelitis in mice.

Authors:  Katja Schmitz; Annett Wilken-Schmitz; Verica Vasic; Robert Brunkhorst; Mirko Schmidt; Irmgard Tegeder
Journal:  Cell Mol Immunol       Date:  2019-08-29       Impact factor: 11.530

Review 5.  Pharmacological insights into autophagy modulation in autoimmune diseases.

Authors:  Ming-Yue Wu; Er-Jin Wang; Du Feng; Min Li; Richard D Ye; Jia-Hong Lu
Journal:  Acta Pharm Sin B       Date:  2021-03-22       Impact factor: 11.413

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.